Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism
The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
AIMS: Many trials have been conducted to assess the efficacy of various strategies in the prevention of venous thrombo-embolism (VTE). Some of these trials have been subject to methodological criticisms. We aimed to assess the methodological issues raised by VTE trials. METHODS AND RESULTS: We searched MEDLINE and the Cochrane Central Register of Controlled Trials for articles assessing primary thromboprophylaxis published between 1994 and 2003 in 60 general medical and specialty journals. A total of 77 articles were analysed by two independent reviewers using a list of items. No primary endpoint was defined in 20% of trials. Although the primary endpoint was collected before day 15 in 75% of trials, there were >/=20% missing data in 56% of articles and >/=30% in 24.2% of articles. The rate of missing data was 23.7+/-9.7% in studies using venography-detected deep-vein thrombosis as an endpoint compared with 5.6+/-6.0% in studies using other endpoints. Among the 47 superiority trials, 27 (57.4%) reported an intention-to-treat (ITT) analysis, but only 10 (21.3%) reported an analysis that complied with this principle. These results were consistent when limiting the analysis to articles published in high-impact journal (impact factor more than 5). CONCLUSION: Recent randomized controlled trials assessing prophylactic regimens in VTE have important methodological limitations in terms of primary endpoints, missing data, and compliance with the ITT principle. These methodological shortcomings should be addressed when planning future trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, some studies report “double-blind” methods, but the blinding is not credible (11, 12), or report an intent-to-treat analysis, but some patients are excluded from the analysis (13, 14).”
From Misrepresentation and distortion of research in biomedical literature (2018) · cites this paper as [14]
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Prevention of Venous Thromboembolism
Geerts, W. H., Heit, J. A., Clagett, G. P., Pineo, G. F., Colwell, C. W., Anderson, F. A., & Wheeler, H. B. (2001) · Chest · doi:10.1378/chest.119.1_suppl.132s · Cited by 4,373
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Samama, M. M., Cohen, A. T., Darmon, J.-Y., Desjardins, L., Eldor, A., Janbon, C., Leizorovicz, A., Nguyen, H., Olsson, C.-G., Turpie, A. G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411103 · Cited by 1,584
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314 · cited 2×
“(14) Colwell CW Jr, Spiro TE, Trowbridge AA, Morris BA, Kwaan HC, Blaha JD, Comerota AJ, Skoutakis VA.”
BackgroundMoher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308 · cited 1×
“(6) Bauer KA, Eriksson BI, Lassen MR, Turpie AG.”
BackgroundDuration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012385 · Cited by 1,052
Natural History of Venous Thromboembolism
Kearon, C. (2003) · Circulation · doi:10.1161/01.cir.0000078464.82671.78 · Cited by 1,048 · cited 2×
“J Bone Joint Surg Am 2001;83-A(3):336–345.”
Editorial: Cerebral Palsy—the International Consensus Statement
Clements, R. V., & Simanowitz, A. (2000) · Clinical Risk · doi:10.1177/135626220000600401 · Cited by 856
international consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Cited by
Eriksson, B. I., Dahl, O. E., Rosencher, N., Kurth, A. A., van Dijk, C. N., Frostick, S. P., Prins, M. H., Hettiarachchi, R., Hantel, S., Schnee, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61445-7 · Cited by 1,116
Misrepresentation and distortion of research in biomedical literature
Boutron, I., & Ravaud, P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710755115 · Cited by 273
“For example, some studies report “double-blind” methods, but the blinding is not credible (11, 12), or report an intent-to-treat analysis, but some patients are excluded from the analysis (13, 14).”
BackgroundSelf-citationA tutorial on methodological studies: the what, when, how and why
Mbuagbaw, L. C. E., Lawson, D. O., Puljak, L., Allison, D. B., & Thabane, L. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-01107-7 · Cited by 200
Baron, G., Ravaud, P., Samson, A., & Giraudeau, B. (2008) · Arthritis Care & Research · doi:10.1002/art.23253 · Cited by 37
Self-citationEmbellissement des données : fraude a minima, incompétence ou un mélange des deux
Séror, R., & Ravaud, P. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.05.004 · Cited by 15
Self-citation
Metadata
- Authors
- Thabut, G., Estellat, C., Boutron, I., Samama, C. M., & Ravaud, P.
- Affiliations
- Inserm (FR)
- American College of Cardiology (US)
- Corresponding author
- Thabut, Gabriel
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-10-13
- Volume
- 27
- Issue
- 2
- Pages
- 227-236
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2171363126
- Cited by
- 11
- References
- 97
- Citations by year
- 2023: 1 · 2020: 1 · 2018: 1 · 2012: 2
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Keywords
- venous thromboembolism, primary thromboprophylaxis, methodological quality of trials, missing data, intention-to-treat analysis, deep vein thrombosis, venography, randomized controlled trials, trial reporting quality
- MeSH terms
- Humans, Risk Factors, Thromboembolism, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, Venous Thrombosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism. https://app.cochat.ai/papers/10.1093/eurheartj/ehi587
- The paper
- Thabut, G., Estellat, C., Boutron, I., Samama, C. M., & Ravaud, P. (2006). Methodological issues in trials assessing primary prophylaxis of venous thrombo-embolism. European Heart Journal. https://doi.org/10.1093/eurheartj/ehi587
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.